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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYHumanepithelia are organized in ahierarchical structure,where stemcells generate terminallydifferentiated cells via intermediate progen-
itors. This two-step differentiationprocess is conserved in all tissues, but it is not knownwhether a commongene set contributes to its regu-
lation.Here,we show that retinoic acid (RA) regulates earlyhumanprostate epithelial differentiationby activating a tightly coexpressed set
of 80 genes (e.g., TMPRSS2). Response kinetics suggested that some of these genes could be direct RA targets, whereas others are probably
responding indirectly toRAstimulation.Comparativebioinformatic analysesofpublished tissue-specificmicroarrays anda large-scale tran-
scriptomic data set revealed that these 80 genes are not only RA responsive but also significantly coexpressed inmany human cell systems.
The same gene set preferentially responds to androgens during terminal prostate epithelial differentiation, implying a cell-type-dependent
interplay between RA and tissue-specific transcription factor-mediated signaling in regulating the two steps of epithelial differentiation.INTRODUCTION
Differentiation of self-renewing adult human epithelial
stem cells into rapidly proliferating progenitor cells is a
conserved early event in human tissue development and
homeostasis. Systematic and coordinated regulation by
master transcription factors, noncoding RNA-mediated
networks, or the establishment of progressive epigenetic
marks have been proposed as likely regulatorymechanisms
(Hanna et al., 2010). Identification of control mechanisms
will enable the basic understanding of epithelial dynamics
and could identify common perturbations leading to the
disruption of epithelial homeostasis in cancers. We have
investigated the nature of stem cell regulation during early
human epithelial differentiation using patient-derived
prostate epithelium as our primary experimental tool. In
human prostate, stem-like cells (SCs) of a basal phenotype
and their early differentiated progeny (transit amplifying
[TA] and committed basal cells [CB]) can be reproducibly
enriched from patient-derived benign and malignant tis-
sues by selecting for differential CD133, CD44, and a2b1 in-
tegrin expression (Collins et al., 2005; Richardson et al.,
2004). Transcriptional profiling of prostate SCs and CBs
identified consistent gene expression changes associated
with differentiation and carcinogenesis (Birnie et al.,
2008). We have now investigated the expression pattern
and the regulation of genes that are differentially expressed180 Stem Cell Reports j Vol. 2 j 180–188 j February 11, 2014 j ª2014 The Ain the SC and CB populations, supplemented by a large-
scale analysis of published transcriptomic experiments, to
identify shared signaling pathways that regulate general
epithelial differentiation.RESULTS AND DISCUSSION
Identification of Genes Coregulated during Prostate
Stem Cell Differentiation
Coexpression analysis was performed on differentially
expressed Affymetrix probes between SC and CB from
the Birnie et al. (2008) data set (Figure 1A) to identify func-
tionally related and coregulated genes without intro-
ducing observer or selection bias (Lee et al., 2004). Probes
with high pairwise correlation (Pearson’s correlation coef-
ficient, R R 0.8 or R % 0.8) were clustered into four
distinct groups (A–D) (Figures 1B and 1C). All the correla-
tions (above the threshold) were positive and no signifi-
cant connections between probes within the four groups
were seen. Analysis of independent published microarrays
(Shepherd et al., 2008) showed similar changes in the
expression of group A–D genes during prostate stem cell
differentiation (data not shown). Gene ontology (GO)
analysis further revealed that the genes in each group are
functionally related. Groups B, C, and D genes were prin-
cipally enriched for differentiation-associated processesuthors
A
B
C Figure 1. Identification of Coregulated
Genes
(A) Selection of differentially expressed
probes between SC and CB (p < 0.01; log2
fold change R 0.75) are represented as
black dots in the Birnie et al. (2008)
microarray data.
(B) Differentially expressed probes were
clustered in distinct A–D groups on coex-
pression analysis. Principal GO terms en-
riched for groups B and C are shown below
the group name. Group A was not enriched
for any GO terminology, whereas group C
was enriched for genes involved in (lens)
development.
(C) Normalized expression of group A–D
probes. Probes overexpressed in committed
basal cells (CB) are above the horizontal line
at 0 (groups A and C) and probes overex-
pressed in stem-like cells (SC) (groups B
and D) are below the line. Boxplot
shows minimum, 25%, median, 75%, and
maximum.
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Two-Step Prostate Epithelial Differentiation(Figure 1B). Group C genes exhibited a distinct enrichment
for genes constituting the ‘‘epidermal differentiation com-
plex’’ (SPRR and S100 families) (Benitah, 2012; Mischke
et al., 1996). Interactive Pathway Analysis (IPA) (Kececio-
glu and Kim, 2006) of group C further revealed a signifi-
cant enrichment for genes having critical functions in
generic ‘‘tissue developmental events’’ (p < 0.01) and genes
known to be coregulated by strong differentiation-associ-
ated regulators such as retinoic acid (RA) (p = 2.94 3
1013) and ROCK2 (p = 9.89 3 108). IPA analysis did
not provide convincing evidence for differentiation-asso-
ciated coregulation of group B. These results framed the
hypothesis that group C genes could be coexpressed in a
variety of human tissues and could play a broader func-
tional role in differentiation.
Gene Sets Coexpressed during Prostate Stem Cell
Differentiation Are Coexpressed in the Majority of
Human Cell Types
A compendium data set of 24,536 human Affymetrix mi-
croarrays from 806 experiments, representing at least 150
distinct human cell types, was generated to test whether
group A–D genes are coexpressed acrossmultiple cell types,
pathologies, and treatments (Figures 2A and 2B). This dataStem Cellset is the largest singly normalized human microarray data
set we are aware of. Unlikemost others (Rhodes et al., 2007;
Seita et al., 2012), it is not restricted to any particular sam-
ple type, tissue type, or pathology. Assessment of the raw
microarray data for technical and experimental accuracies
resulted in the removal of 507 corrupted or experimentally
faulty experiments (Supplemental Experimental Proce-
dures available online). Overall, the final data set yielded
about 1.2 billion expression correlations between genes.
We confirmed the quality and utility of this data set
for gene variation analysis by performing GO analysis on
the 100 least variable probes, which identified the most
invariable genes (by coefficient of variation after normali-
zation) in human cells, e.g., ribosomal genes and control
genes for quantitative RT-PCR (qRT-PCR)/western blot
normalization (Table S1). The data set can also be used to
construct background interaction modeling to identify in-
teractions representing normal physiology or common oc-
currences. Overlaying this background network on a tran-
scriptomic data set of interest facilitates removal of
background interactions, leaving behind experiment-
specific biological behavior. However, the more restricted
analysis in this study clearly demonstrated that group
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lial differentiation show similar expression patterns (and
thus could share common functions and regulation) in
multiple human cell types.
Group C Genes Are Likely Markers or Mediators of
Stem Cell Differentiation
While group B genes showed stronger coexpression in the
compendium data set and exhibited interesting GO term
enrichment, group C genes provided more compelling
evidence for their coregulatory and differentiation-associ-
ated properties. IPA and literature analyses (62 out of 80
genes in group C had at least one PubMed publication link-
ing them to differentiation) strongly implied differentia-
tion-specific coregulation of group C. We selected LCN2,
CEACAM6, S100P, and TMPRSS2 as group C representative
genes to assess group C coregulation, on the basis of strong
evidence for their role in SC differentiation or prostate
epithelial dynamics and their tight coexpression pattern.
Microarray expression of the candidate genes (Figure 2D)
was confirmed by both qRT-PCR (Figure S1) and western
blot analysis (Figure 2E). In a wide variety of mammalian
tissues, low expression of these genes has been shown to
denote SC properties (He et al., 2009; Polson et al., 2013;
Zheng et al., 2009). Furthermore, TMPRSS2 and S100P are
considered to be classical androgen responsive genes in
terminally differentiated cells, which can promote onco-
genesis in prostate epithelium (Averboukh et al., 1996;
Lin et al., 1999), and S100P has also been shown to be
responsible for PC3 cell differentiation into luminal-like
cells (Floryk and Thompson, 2008). Similar functions
therefore translate into tight coexpression of the genes
within the compendium data set, where S100P had a
more similar expression pattern to that of LCN2 and CEA-
CAM6 than any other gene in the human genome (Fig-
ure 2F). TMPRSS2 was also significantly coexpressed with
these three genes (Figure 2F). Such functional attributes
and bioinformatic analyses both indicated that LCN2,
CEACAM6, S100P, and TMPRSS2 (and group C) are coregu-
lated during prostate SC differentiation.Figure 2. Genes in Groups A–D Are Coexpressed in the Majority o
(A) Overview of the composition of compendium data set.
(B) Schematic representation of the methodology for the compendiu
(C) Correlation of coexpression of genes in groups A–D compared to al
different where the p value is computationally indistinguishable from
(D) Expression of candidate group C genes in the Birnie et al. (2008) m
cells; BC, benign committed basal cells; MC, malignant committed ba
(E) Western blot analysis of LCN2, CEACAM6, and S100P expression.
(BPH) and treatment-naı̈ve prostate cancer (PCa) (biological replicat
(F) Rainbow contour graphs for the correlation of coexpression for TM
data set. Values at the top of each square indicate correlation coeffic
All boxplots show minimum, 25%, median, 75%, and maximum. See
Stem CellRetinoic Acid Regulates Group CGenes Inducing Early
Prostate Stem Cell Differentiation
Multiple bioinformatic tools and a published literature
evaluation were utilized to identify potential regulators of
group C genes (Figure 3A). The analyses identified RA as
the most likely regulator of gene expression because (1)
IPA analysis suggested that RA can regulate group C; (2)
ENCODE chromatin immunoprecipitation (ChIP) analysis
of HepG2 cells also showed a significant enrichment for
retinoid X receptor a (RXRA) binding sites on the pro-
moters of group C; (3) LCN2, CEACAM6, S100P, and
TMPRSS2 have putative RAR and RXR binding sites within
their promoters (data not shown); (4) our previous work
has demonstrated that two other genes in group C
(RARRES1 and LXN) are also directly regulated by RA (Old-
ridge et al., 2013); and (5) RA-related transcription factors
(RXRa, RARg, and RARa) are actively expressed in prostate
epithelial cells (Figures 3B and S2). RA acts as an important
regulator of both embryonic and adult SC differentiation.
However, in spite of strong historical evidence for a role
in the developing mouse prostate (Lohnes et al., 1995),
the outcome of RA signalingmanipulation in adult human
prostate epithelial differentiation is unknown. The case for
transcription-factor-mediated regulation of group C is also
enhanced by the lack of evidence for a common regulatory
mechanism in terms of microRNA, histone acetylation,
and DNA methylation even for the group C candidate
genes (data not shown).
To test whether RA is indeed a principal regulator of
prostate epithelial SC differentiation, benign and malig-
nant patient-derived prostate epithelial cells (PPECs) were
treated with 100 nM all-trans retinoic acid (at-RA). The
group C candidate genes showed a 4- to 60-fold increase
in expression within 72 hr (Figures 3C–3F), accompanied
by a modest but statistically insignificant decrease in
cell number (not shown). The rapid increase in TMPRSS2
expression levels (6 hr posttreatment) suggested that this
gene could be a direct target of RA, whereas the other three
genes responded more slowly and are more likely, on a
kinetic basis, to be RA-‘‘responsive’’ genes. A similar trendf Human Cell Types
m data set.
l genes in the compendium data set. All the groups are significantly
zero.
icroarray data. BS, benign stem-like cells; MS, malignant stem-like
sal cells.
Representative image, n = 6 each for benign prostatic hyperplasia
es).
PRSS2, CEACAM6, LCN2, and S100P with each other in compendium
ient. All values are significant with p < 0.05.
also Figure S1 and Table S1.
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Two-Step Prostate Epithelial Differentiationwas also noted in at-RA-treated prostate SCs (Figure 3G).
The RA responsiveness of these genes has been shown
in other experimental models; for example, LCN2, S100P,
and CEACAM6 were upregulated in sebaceous cells after
13-cis-RA treatment (Nelson et al., 2008). Analysis of publi-
cally available microarray data (Figure 3H) confirmed that
group C genes are also upregulated in response to RA treat-
ment in four different cell types, including human embry-
onic SCs. Taken together, these findings demonstrate that
the majority of group C genes are RA-responsive genes.
Next, we assessed whether RA treatment alone, while
modulating group C expression, could also induce early
prostate SC differentiation. Treatment of PPECs with
100 nM at-RA for 72 hr induced (1) suppression of col-
ony-forming efficiency by approximately 60% (Figure 3I),
indicating a decrease in self-renewing cells; (2) a >50%
decrease in the expression of the progenitor cell marker
CD49f (Figures 3J and 3K) and a 12% decrease in CD49b
expression (data not shown); (3) a decrease in CK5 (basal
CK) expression with a concomitant increase in luminal
CK18 expression (Figures 3L–3N); (4) a decrease in
NF-kB1 and ID2 expression levels, which promote a SC
phenotype; and (5) increased expression of the differentia-
tion-associated genes WNT5a and PAP (Figure 3O) (Birnie
et al., 2008). Classical prostate luminal differentiation
markers, such as AR, PSA, and NKX3.1, remained unaltered
after at-RA treatment (Figure 3O). A similar increase in
endogenous RA levels in prostate cancer patients after
treatment with liarozole also resulted in aminimal increase
in luminal differentiation (Denis et al., 1998). Two human
clinical trials also showed only a modest increase in the
expression of PSA and PAP (in only about 30% of
patients). These findings indicated that at-RA treatmentFigure 3. Retinoic Acid Can Regulate Group C while Inducing Earl
(A) Schematic representation for selection process of retinoic acid (R
(B) Expression of RA receptors in primary prostate epithelial cultures
for BPH and PCa (biological replicates). Scale bar: 62 mm.
(C–F) qRT-PCR analysis of CEACAM6, LCN2, S100P, and TMPRSS2 express
(2) (biological replicates).
(G) qRT-PCR analysis of CEACAM6, LCN2, S100P, and TMPRSS2 expressi
(five) and PCa (four) (biological replicates).
(H) Changes in the expression of group C genes after RA treatment in
(I) Changes in colony-forming efficiency of PPECs after 72 hr 100 nM
(J and K) Fluorescence-activated cell sorting analysis of CD49f express
BPH and PCa (biological replicates). In (J), the blue line indicates DMS
lines represent unlabeled controls.
(L) Immunofluorescence (IF) analysis of KRT5 and KRT18 after 72 hr
(M and N) Quantification of changes in KRT5 (M) and KRT18 (N) protei
using velocity software.
(O) qRT-PCR expression analysis of markers of prostate epithelial diffe
each for BPH and PCa (biological replicates).
Error bars represent mean ± SD. *p < 0.05, **p < 0.01, and ***p < 0.00
and maximum. See also Figure S2.
Stem Cellcan induce differentiation of prostate SCs to CBs, which
are primed for luminal differentiation (as suggested by
the increase in PAP and CK18 levels) but confirm that RA
alone cannot force luminal differentiation. In this scenario,
overexpression of all the candidate group C genes in
luminal cells (Oudes et al., 2006) prompted us to assess
the existence of additional regulators of group C genes in
prostate epithelial differentiation.
Androgens Can Regulate Group C during Terminal
Human Prostate Epithelial Differentiation
The majority of group C genes were indeed overexpressed
in patient-derived luminal compared to basal cells (Oudes
et al., 2006) (Figure 4A and S3), implying that another tran-
scription factor, distinct from RA, may regulate group C to
sustain and promote gene expression during luminal differ-
entiation. Because systemic and niche-driven AR-mediated
signaling is themain regulator of luminal differentiation in
prostate and is capable of inducing luminal differentiation,
even in 3D culture, with an obligatory contribution from
stroma (Lang et al., 2006), we assessed the responsiveness
of group C to AR stimulation in publically available micro-
array data. Group C was consistently upregulated upon AR
stimulation inmultipleprostate cell linemodels (Figure4B),
confirming that group C genes can respond to a tissue-spe-
cific transcription factor (like AR) in cells primed for termi-
nal differentiation. However, this presented a conundrum
about the ‘‘principal’’ regulator of group C genes during
prostate epithelial differentiation. We therefore treated
prostate cells, possessing a distinct basal or luminal pheno-
type, with at-RA or R1881 (an AR agonist). In cells with a
basal phenotype, at-RA, but not R1881, upregulated
TMPRSS2 expression (up to 80-fold), whereas TMPRSS2y Prostate Stem Cell Differentiation
A) as a group C regulator.
(PPECs) by immunofluorescence (representative image); n = 3 each
ion after 100 nM at-RA treatment of PPECs; n = 5 for BPH (3) and PCa
on after 100 nM at-RA treatment of SCs; mean values shown for BPH
four published microarray experiments.
at-RA treatment; n = 4 for BPH and PCa.
ion after 72 hr treatment of PPECs with 100 nM at-RA; n = 4 each for
O control, whereas the red line indicates RA-treated samples. Dotted
treatment of PPECs with 100 nM at-RA. Scale bar, 100 mm.
n expression by IF after 72 hr treatment of PPECs with 100 nM at-RA
rentiation after 72 hr treatment of PPECs with 100 nM at-RA; n = 4
1. Box plots in (H), (M), and (N) show minimum, 25%, median, 75%,
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A B
C D
Figure 4. Androgens Regulate Group C
Gene Expression during Terminal
Differentiation
(A) Expression of group A–D genes in pros-
tate luminal cells relative to basal cells.
(B) Changes in expression of group C genes
after androgen stimulation in three pub-
lished microarrays.
(C) qRT-PCR analysis of TMPRSS2 expression
after 48 hr treatment with at-RA (RA) and
R1881 (n = 6 for PPECs [3 BPH and 3 PCa,
biological replicates] and n = 3 for cell lines
[experimental replicates]).
(D) qRT-PCR for the expression of LCN2,
CEACAM6, S100P, TMPRSS2, and PSA in
LNCaP cells after 1 nM bicalutamide treat-
ment for 48 hr. The data are plotted
considering the untreated gene expression
value as 1 (n = 3, experimental replicates).
Error bars represent mean ± SD. Box plots
show minimum, 25%, median, 75%, and
maximum. See also Figures S3 and S4.
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in cells with a luminal phenotype (Figures 4C and S4A).
Similar observations were also made for CEACAM6 and
S100P (Figures S4B and S4C). Inhibition of AR signaling
has also been shown to inhibit the expression of these
genes in LNCaP cells (Figure 4D; Averboukh et al., 1996).
This experimental evidence indicated that RA and AR act
in a cell-type-dependent manner to coregulate group C,
providing a fuller explanation for the observed expression
changes in TMPRSS2 (strongly considered solely as an
androgen-regulated gene) in androgen-independent basal
cells (Polson et al., 2013).
This study provides direct evidence for the mechanistic
role of RA during adult prostate SC differentiation, where
ALDHhi cells with SC properties in prostate (van den
Hoogen et al., 2010) can serve as a potential source of RA.
Prostate epithelial SCs with no detectable AR expression
respond to RA stimulation through a set of 80 genes, trans-
forming SCs into basal cells committed to terminal differ-
entiation (luminal). The genes can then preferentially
respond to androgens during terminal differentiation.
The change in regulatory preference could be due to multi-
ple factors, such as weakening of a RA morphogenetic
gradient from the basal to the luminal layer (Shimozono
et al., 2013), loss of contact with the basement membrane
and niche (Lang et al., 2006), chromatin modifications186 Stem Cell Reports j Vol. 2 j 180–188 j February 11, 2014 j ª2014 The Ainduced by RA (Kashyap et al., 2013), or changes in the
expression of independent differentiation-associated chro-
matin modifying genes (e.g., group B genes). When the
distinction of a basal-luminal cell type is not clear, as in in-
termediate prostate epithelial cells (van Leenders et al.,
2000) and cell lines, competition between RA- and AR-
mediated signaling may result in competitive inhibition
of one of the two response pathways (Young et al., 1994).
The reduced RA content of prostate cancer tissue compared
to normal tissue (Pasquali et al., 1996), where AR-respon-
sive terminally differentiated cells predominate (99% of
total cells), suggests that the tissue strives to minimize
AR-RA antagonism by downregulating the less efficient
signaling mechanism. Cooperation/interference between
RA and AR signaling (Rivera-Gonzalez et al., 2012) may
therefore regulate prostate epithelial differentiation and
dynamics through a similar set of genes. In mammary
epithelial development, RA also regulates early differentia-
tion, whereas a tissue-specific transcription factor (estrogen
receptor) can then promote terminal epithelial differentia-
tion (Förster et al., 2002; Seewaldt et al., 1997). Our data
now reveal the existence of similar two-step regulation of
differentiation in other epithelial tissues.
In terms of prostate cancer management, our data
strongly suggest that RA treatment should lock prostate
cancer stem cells into an AR-independent committed basaluthors
Stem Cell Reports
Two-Step Prostate Epithelial Differentiationcell phenotype, which will not be affected by prevailing
androgen-blocking therapy (Rane et al., 2012). Our data
link two of the most conserved prostate epithelial differen-
tiation-regulatory pathways to a shared gene set, providing
a mechanistic insight into adult human epithelial
dynamics.EXPERIMENTAL PROCEDURES
Establishment of Primary Cultures
Patient tissuematerial was obtained followingwritten consent and
full ethical approval (NHS Research Governance Framework: NRES
reference number 07/H1304/121). Cultures were established from
patient-derived cancer (all Gleason 7) and benign prostatic hyper-
plasia biopsy specimens and SC, TA, and CB cells were selected as
described previously (Collins et al., 2005) at passage 2.
Construction and Analysis of Compendium Data Set
Transcriptomic data were normalized by RMA and annotated.
Row-wise correlation analysis was used to yield a matrix of corre-
lations between all probes. See the Supplemental Experimental
Procedures for additional details.
Expression Analysis
qRT-PCR analysis was performed as described previously (Oldridge
et al., 2013). Details of TaqMan probes and antibodies used
for western blot, fluorescence-activated cell sorting, and immuno-
fluorescence analyses are in the Supplemental Experimental
Procedures.
Colony-Forming Efficiency
A total of 200 cells were plated in each well of a six-well collagen-
coated plate with 500 ml of irradiated mouse fibroblasts. Colonies
generated by individual cells were counted after 12–18 days.
Statistical Analysis
Experiments were carried out with at least three different samples
(each in triplicate) representing at least two different experiments.
Error bars shown are the SD. The significance was determined by
Student’s two-tailed t test. Wilcoxon rank sum test was used to
calculate significance of cytokeratin immunofluorescence.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.01.001.
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